GSK PLC
GSKHealthcare|Drug Manufacturers - General|UK
$52.78
+0.31 (+0.59%)
DCF (FCF)
$40.01
Earnings Power
$32.61
Financials
Financial Snapshot
Market Cap
$105.71B
Enterprise Value
$-20.35B
Revenue (TTM)
$44.09B
Net Income (TTM)
$7.85B
Cash & Equivalents
—
Net Cash/Share
$-27.82
Free Cash Flow (TTM)
$6.41B
Operating CF (TTM)
$10.42B
Debt/Equity
1.07
Cash Runway & Burn Rate
Company is cash-flow positive.
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $6.22B | $5.24B | $5.01B | $6.01B | $8.29B | $5.50B | $9.35B | $6.32B | $4.70B | $4.23B | $4.59B | |
| Operating Cash Flow | $8.11B | $9.27B | $10.66B | $10.51B | $11.35B | $10.57B | $9.02B | $8.57B | $8.29B | $10.36B | $10.42B | |
| Free Cash Flow | $5.17B | $6.32B | $8.39B | $7.68B | $8.73B | $7.05B | $6.27B | $5.60B | $4.52B | $6.37B | $6.41B | |
| Capital Expenditure | $-2.94B | $-2.95B | $-2.27B | $-2.83B | $-2.61B | $-3.53B | $-2.75B | $-2.97B | $-3.77B | $-4.00B | $-4.01B | |
| Financing Cash Flow | $-7.98B | $-8.55B | $-8.09B | $-2.41B | $-13.62B | $-10.09B | $1.00B | $-7.14B | $-5.97B | $-4.93B | $-5.78B |
R&D Spending
R&D (TTM)
$10.43B
R&D Intensity
23.7%
R&D Growth YoY
+3.5%
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34.82B | $40.46B | $39.01B | $44.24B | $32.73B | $32.84B | $35.72B | $38.39B | $39.67B | $43.73B | $44.09B | |
| R&D Expense | $4.53B | $6.00B | $4.93B | $5.99B | $6.44B | $6.67B | $6.68B | $7.88B | $8.09B | $10.07B | $10.43B | |
| R&D % of Revenue | 13.0% | 14.8% | 12.6% | 13.5% | 19.7% | 20.3% | 18.7% | 20.5% | 20.4% | 23.0% | 23.7% | |
| SG&A | $11.69B | $12.97B | $12.55B | $14.94B | $10.00B | $9.40B | $10.20B | $11.88B | $13.93B | $12.17B | $12.29B |
Income Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34.82B | $40.46B | $39.01B | $44.24B | $32.73B | $32.84B | $35.72B | $38.39B | $39.67B | $43.73B | $44.09B | |
| Cost of Goods Sold | $11.60B | $13.86B | $12.96B | $15.55B | $10.66B | $10.86B | $11.64B | $10.84B | $11.44B | $12.07B | $12.05B | |
| Gross Profit | $23.22B | $26.60B | $26.05B | $28.69B | $22.08B | $21.99B | $24.08B | $27.55B | $28.23B | $31.66B | $32.05B | |
| R&D | $4.53B | $6.00B | $4.93B | $5.99B | $6.44B | $6.67B | $6.68B | $7.88B | $8.09B | $10.07B | $10.43B | |
| SG&A | $11.69B | $12.97B | $12.55B | $14.94B | $10.00B | $9.40B | $10.20B | $11.88B | $13.93B | $12.17B | $12.29B | |
| Operating Income | $7.52B | $8.12B | $8.94B | $8.25B | $6.15B | $6.49B | $8.20B | $9.30B | $7.01B | $11.16B | $11.32B | |
| Interest Expense | $-895.1M | $-987.9M | $-878.5M | $-1.15B | $-1.14B | $-1.02B | $-1.01B | $-917.7M | $-809.1M | $-919.7M | $-930.9M | |
| Pretax Income | $2.42B | $4.73B | $6.08B | $8.15B | $6.95B | $4.79B | $6.86B | $7.68B | $4.40B | $9.91B | $10.01B | |
| Net Income | $1.14B | $2.05B | $4.59B | $6.09B | $7.73B | $5.83B | $18.22B | $6.24B | $3.26B | $7.65B | $7.85B | |
| EPS (Diluted) | 0.58 | 1.04 | 2.31 | 3.03 | 3.83 | 2.88 | 8.92 | 3.04 | 1.57 | 3.72 | 3.83 | |
| EBITDA | $5.53B | $8.29B | $9.30B | $12.36B | $10.84B | $8.62B | $10.48B | $11.50B | $8.43B | $13.93B | $14.13B | |
| Shares Out. (M) | 1963.60 | 1976.40 | 1988.40 | 2006.40 | 2015.00 | 2026.00 | 2042.00 | 2055.50 | 2071.00 | 2058.50 | 2037.00 |
Balance Sheet
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.11B | $5.14B | $4.90B | $5.91B | $8.19B | $5.42B | $4.29B | $3.48B | $4.67B | $4.22B | $4.59B | |
| Marketable Securities | $111.1M | $104.6M | $106.3M | $103.5M | $104.8M | $81.1M | $5.06B | $2.84B | $26.5M | $12.0M | $1.3M | |
| Total Current Assets | $20.86B | $21.32B | $21.43B | $25.55B | $27.21B | $24.83B | $25.30B | $23.60B | $21.49B | $23.44B | $23.68B | |
| Total Assets | $73.76B | $75.58B | $73.50B | $104.45B | $108.11B | $105.19B | $73.26B | $74.69B | $75.17B | $81.82B | $83.83B | |
| Total Current Liabilities | $23.72B | $35.62B | $28.47B | $31.52B | $29.77B | $31.48B | $27.78B | $26.67B | $27.43B | $28.64B | $29.91B | |
| Long-Term Debt | $18.25B | $19.06B | $25.60B | $29.59B | $30.29B | $26.28B | $19.72B | $17.92B | $17.32B | $18.76B | $0.00 | |
| Total Liabilities | $67.56B | $70.90B | $68.85B | $80.39B | $80.14B | $76.81B | $60.96B | $58.49B | $58.63B | $60.46B | $60.60B | |
| Stockholders' Equity | $1.40B | $-91.2M | $4.79B | $14.95B | $19.61B | $20.02B | $12.91B | $16.89B | $17.28B | $21.92B | $23.80B | |
| Retained Earnings | $-6.73B | $-8.68B | $-3.44B | $5.94B | $9.08B | $10.56B | $5.31B | $9.16B | $9.86B | $13.67B | $15.45B |
Cash Flow Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.11B | $9.27B | $10.66B | $10.51B | $11.35B | $10.57B | $9.02B | $8.57B | $8.29B | $10.36B | $10.42B | |
| Capital Expenditure | $-2.94B | $-2.95B | $-2.27B | $-2.83B | $-2.61B | $-3.53B | $-2.75B | $-2.97B | $-3.77B | $-4.00B | $-4.01B | |
| Free Cash Flow | $5.17B | $6.32B | $8.39B | $7.68B | $8.73B | $7.05B | $6.27B | $5.60B | $4.52B | $6.37B | $6.41B | |
| Investing Cash Flow | $-1.58B | $-1.93B | $-1.97B | $-7.02B | $2.90B | $-2.36B | $-10.68B | $-2.02B | $-1.55B | $-5.67B | $-6.12B | |
| Financing Cash Flow | $-7.98B | $-8.55B | $-8.09B | $-2.41B | $-13.62B | $-10.09B | $1.00B | $-7.14B | $-5.97B | $-4.93B | $-5.78B | |
| Issuance of Stock | $111.1M | $75.1M | $93.7M | $66.8M | $39.0M | $27.9M | $30.5M | $12.7M | $25.3M | $20.1M | $14.7M | |
| Repurchase of Stock | $-92.4M | $-87.1M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1.84B | $-1.96B | |
| Issuance of Debt | $1.33B | $2.99B | $12.94B | $10.34B | $4.43B | $400.3M | $2.49B | $282.3M | $1.70B | $4.28B | $3.11B | |
| Payments of Debt | $-1.15B | $-4.29B | $-2.62B | $-5.45B | $-9.85B | $-3.06B | $-8.12B | $-3.28B | $-3.17B | $-2.26B | $-2.10B | |
| Stock Based Comp. | $398.3M | $446.4M | $455.7M | $478.4M | $453.0M | $456.1M | $421.4M | $388.6M | $434.9M | $500.7M | $0.00 | |
| Net Change in Cash | $-1.10B | $-1.35B | $616.5M | $975.1M | $579.3M | $-1.92B | $-479.9M | $-717.7M | $689.0M | $-262.4M | $-1.49B |
Dilution Tracker
Shares Outstanding
2037M
5-Year Share Growth
+0.5%
Stock Issuance (TTM)
$14.7M
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 1963.60 | 1976.40 | 1988.40 | 2006.40 | 2015.00 | 2026.00 | 2042.00 | 2055.50 | 2071.00 | 2058.50 | 2037.00 | |
| YoY Change % | — | 0.7% | 0.6% | 0.9% | 0.4% | 0.5% | 0.8% | 0.7% | 0.8% | -0.6% | -1.0% | |
| Stock Issuance | $111.1M | $75.1M | $93.7M | $66.8M | $39.0M | $27.9M | $30.5M | $12.7M | $25.3M | $20.1M | $14.7M | |
| Stock Repurchase | $-92.4M | $-87.1M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1.84B | $-1.96B | |
| Stock Based Comp. | $398.3M | $446.4M | $455.7M | $478.4M | $453.0M | $456.1M | $421.4M | $388.6M | $434.9M | $500.7M | $0.00 |
Margins & Profitability
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 66.7% | 65.7% | 66.8% | 64.9% | 67.4% | 66.9% | 67.4% | 71.8% | 71.2% | 72.4% | 72.7% | |
| Operating Margin % | 21.6% | 20.1% | 22.9% | 18.6% | 18.8% | 19.8% | 22.9% | 24.2% | 17.7% | 25.5% | 25.7% | |
| Net Margin % | 3.3% | 5.1% | 11.8% | 13.8% | 23.6% | 17.8% | 51.0% | 16.2% | 8.2% | 17.5% | 17.8% | |
| EBITDA Margin % | 15.9% | 20.5% | 23.8% | 27.9% | 33.1% | 26.3% | 29.3% | 29.9% | 21.3% | 31.8% | 32.0% | |
| FCF Margin % | 14.9% | 15.6% | 21.5% | 17.4% | 26.7% | 21.5% | 17.5% | 14.6% | 11.4% | 14.6% | 14.5% | |
| ROE % | 25.1% | 313.0% | 195.4% | 61.7% | 44.7% | 29.4% | 110.6% | 41.9% | 19.0% | 39.0% | 37.0% | |
| ROA % | 1.5% | 2.8% | 6.2% | 6.8% | 7.3% | 5.5% | 20.4% | 8.4% | 4.3% | 9.7% | 9.6% | |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - | - |
Valuation
P/E (TTM)13.77
Historical3.49 / 15.18 / 2438.53
Industry Med.20.77
P/S2.45
Historical1.53 / 2.08 / 3.48
Industry Med.2.30
P/B4.42
Historical3.26 / 4.78 / 491.88
Industry Med.1.91
EV/EBITDA8.94
Historical7.27 / 10.33 / 29.44
Industry Med.12.99
EV/Revenue2.86
Historical2.11 / 2.74 / 5.00
Industry Med.2.45
P/FCF16.89
Historical7.11 / 12.35 / 44.45
Industry Med.20.81
Intrinsic Value Models
DCF (FCF Based)
$40.01
Median P/S Value
$45.02
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PE Ratio | 67.53 | 34.34 | 16.49 | 15.48 | 9.48 | 14.96 | 3.93 | 12.10 | 21.65 | 13.14 | 13.77 | |
| PS Ratio | 2.22 | 1.74 | 1.94 | 2.13 | 2.24 | 2.66 | 2.00 | 1.97 | 1.78 | 2.30 | 2.45 | |
| PB Ratio | 55.46 | 0.00 | 16.30 | 6.45 | 3.88 | 4.56 | 5.57 | 4.45 | 3.99 | 4.49 | 4.42 | |
| EV/EBITDA | 17.93 | 11.25 | 11.11 | 11.07 | 10.12 | 14.11 | 8.33 | 7.85 | 10.14 | 8.40 | 8.94 | |
| EV/Revenue | 2.85 | 2.30 | 2.65 | 3.09 | 3.35 | 3.70 | 2.44 | 2.35 | 2.16 | 2.67 | 2.86 |
Analyst Estimates & Quality
Altman Z-Score
2.15
Grey Zone
Piotroski F-Score
8
Strong
Beneish M-Score
-2.43
Unlikely Manipulator
Forward Estimates
| Metric | Current Year | Next Year | 2 Years Out |
|---|---|---|---|
| Revenue | $44,874M | $47,155M | $48,597M |
| Net Income | $9,328M | $10,263M | $10,686M |
| EPS | 2.67 | 2.90 | 2.49 |
| Book Value per Share | 12.85 | 15.29 | 17.71 |
| Operating Cash Flow per Share | 4.87 | 5.40 | 5.84 |
| Operating CF | $9,918.15M | $10,991.65M | $11,892.01M |
Dividends
Dividend/Share (TTM)
$1.78
Dividend Yield
3.40%
Yield 10Y Median
6.01%
Frequency
Quarterly
Recent Payments
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| 2026-05-15 | 2026-07-09 | $0.45496 | Cash Div. |
| 2026-02-20 | 2026-04-09 | $0.477611 | Cash Div. |
| 2025-11-14 | 2026-01-08 | $0.433113 | Cash Div. |
| 2025-08-15 | 2025-10-09 | $0.42996 | Cash Div. |
| 2025-05-16 | 2025-07-10 | $0.434774 | Cash Div. |
| 2025-02-21 | 2025-04-10 | $0.407568 | Cash Div. |
| 2024-11-15 | 2025-01-09 | $0.376892 | Cash Div. |
| 2024-08-16 | 2024-10-10 | $0.392813 | Cash Div. |
| 2024-05-16 | 2024-07-11 | $0.384301 | Cash Div. |
| 2024-02-22 | 2024-04-11 | $0.404885 | Cash Div. |
| 2023-11-16 | 2024-01-11 | $0.356356 | Cash Div. |
| 2023-08-17 | 2023-10-12 | $0.343532 | Cash Div. |
| 2023-05-18 | 2023-07-13 | $0.360944 | Cash Div. |
| 2023-02-23 | 2023-04-13 | $0.341883 | Cash Div. |
| 2022-11-17 | 2023-01-12 | $0.334785 | Cash Div. |
| 2022-08-18 | 2022-10-06 | $0.36946 | Cash Div. |
| 2022-05-19 | 2022-07-01 | $0.437031 | Cash Div. |
| 2022-02-24 | 2022-04-07 | $0.754316 | Cash Div. |
| 2021-11-18 | 2022-01-13 | $0.646043 | Cash Div. |
| 2021-08-19 | 2021-10-07 | $0.646891 | Cash Div. |
Revenue Segments
By Business
| Segment | 2025 |
|---|---|
| Commercial Operations | $32.67B |
By Geography
| Segment | 2025 |
|---|---|
| United States (US) | $16.86B |
| Europe | $6.85B |
| International | $8.28B |
| United Kingdom (UK) | $683.0M |